The African COVID-19 Vaccine Development and Access Strategy of the African Union (AU), yesterday, admitted that its target of vaccinating at least 60 per cent of the continent’s population (about 750 million people) or the entire adult populace by end of 2022 had suffered a setback, as only less than two per cent of Africans had received the jabs.
The Africa Centres for Disease Control and Prevention (Africa CDC) said the vaccines available to the continent represent a small portion of global supplies, even as purchase, delivery and administration of the doses remain significant.
Speaking at the launch of a partnership between MasterCard Foundation and Africa CDC, the centre’s Director, Dr. John Nkengasong, maintained that ensuring inclusivity in vaccine access and building continental capacity to manufacture its vaccines remained only the sustainable path to a healthy future.
On the pact, he said it would build on efforts of the COVID-19 Vaccines Global Access facility (COVAX), COVID-19 African Vaccine Acquisition Task Team (AVATT) and the global community to expand access to the jabs across Africa.
“This partnership with the MasterCard Foundation is a bold step towards establishing a New Public Health Order for Africa and we welcome other actors to join this historic journey,” Nkengasong stated.
The Africa CDC called on governments, global funders, the private sector and others to assist in meeting the AU goals.
Source: The Guardian NG